Interactions between schwann cells and macrophages in injury and inherited demyelinating disease

GLIA

Volumn 56, Issue 14, 2008, Pages 1566-1577

  Martini, Rudolf ^a   Fischer, Stefan ^a   López Vales, Rubèn ^b   David, Samuel ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Chemokines; Cytokines; Demyelination; Macrophage; Schwann cell; Wallerian degeneration

Indexed keywords

CHEMOKINE; CYTOKINE;

ANIMAL; CYTOLOGY; HUMAN; IMMUNOLOGY; INJURY; MACROPHAGE; METABOLISM; MYELIN SHEATH; NERVE DEGENERATION; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NERVE; POLYRADICULONEUROPATHY; REVIEW; SCHWANN CELL;

ANIMALS; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; HUMANS; MACROPHAGES; MYELIN SHEATH; PERIPHERAL NERVES; POLYRADICULONEUROPATHY; SCHWANN CELLS; WALLERIAN DEGENERATION;

EID: 61549129995     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20766     Document Type: Article

References (121)

1. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, Gherardi RK, Chazaud B. 2007. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 204:1057-1069.
2. Avellino AM, Hart D, Dailey AT, MacKinnon M, Ellegala D, Kliot M. 1995. Differential macrophage responses in the peripheral and central nervous system during wallerian degeneration of axons. Exp Neurol 136:183-198.
3. Be'eri H, Reichert F, Saada A, Rotshenker S. 1998. The cytokine network of wallerian degeneration: IL-10 and GM-CSF. Eur J Neurosci 10:2707-2713.
4. Bell MD, Lopez-Gonzalez R, Lawson L, Hughes D, Fraser I, Gordon S, Perry VH. 1994. Upregulation of the macrophage scavenger receptor in response to different forms of injury in the CNS. J Neurocytol 23:605-613.
5. Bendszus M, Stoll G. 2003. Caught in the act: In vivo mapping of macrophage infiltration in nerve injury by magnetic resonance imaging. J Neurosci 23:10892-10896.
6. Berger P, Niemann A, Suter U. 2006. Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease). Glia 54:243-257.
7. Berghoff M, Samsam M, Muller M, Kobsar I, Toyka KV, Kiefer R, Maurer M, Martini R. 2005. Neuroprotective effect of the immune system in a mouse model of severe dysmyelinating hereditary neuropathy: Enhanced axonal degeneration following disruption of the RAG-1 gene. Mol Cell Neurosci 28:118-127.
8. Beuche W, Friede RL. 1985. Millipore diffusion chambers allow dissociation of myelin phagocytosis by non-resident cells and of allogenic nerve graft rejection. J Neurol Sci 69:231-246.
9. Boivin A, Pineau I, Barrette B, Filali M, Vallieres N, Rivest S, Lacroix S. 2007. Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury. J Neurosci 27:12565-12576.
10. Boven LA, Van Meurs M, Van Zwam M, Wierenga-Wolf A, Hintzen RQ, Boot RG, Aerts JM, Amor S, Nieuwenhuis EE, Laman JD. 2006. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 129(Part 2):517-526.
11. Boyd JG, Gordon T. 2003. Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury. Mol Neurobiol 27:277-324.
12. Bray GM, Peyronnard JM, Aguayo AJ. 1972. Reactions of unmyelinated nerve fibers to injury. An ultrastructural study. Brain Res 42:297- 309.
13. Brown MC, Lunn ER, Perry VH. 1992. Consequences of slow Wallerian degeneration for regenerating motor and sensory axons. J Neurobiol 23:521-536.
14. Bruck W. 1997. The role of macrophages in Wallerian degeneration. Brain Pathol 7:741-752.
15. Bruck W, Friede RL. 1991. The role of complement in myelin phagocytosis during PNS wallerian degeneration. J Neurol Sci 103:182-187.
16. Bruck W, Huitinga I, Dijkstra CD. 1996. Liposome-mediated monocyte depletion during wallerian degeneration defines the role of hematogenous phagocytes in myelin removal. J Neurosci Res 46:477-484.
17. Carenini S, Maurer M, Werner A, Blazyca H, Toyka KV, Schmid CD, Raivich G, Martini R. 2001. The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in p0. J Cell Biol 152:301-308.
18. Chattopadhyay S, Myers RR, Janes J, Shubayev V. 2007. Cytokine regulation of MMP-9 in peripheral glia: Implications for pathological processes and pain in injured nerve. Brain Behav Immun 21:561- 568.
19. Cheepudomwit T, Guzelsu E, Zhou C, Griffin JW, Hoke A. 2008. Comparison of cytokine expression profile during Wallerian degeneration of myelinated and unmyelinated peripheral axons. Neurosci Lett 430:230-235.
20. Chen YY, McDonald D, Cheng C, Magnowski B, Durand J, Zochodne DW. 2005. Axon and Schwann cell partnership during nerve regrowth. J Neuropathol Exp Neurol 64:613-622.
21. Chitu V, Stanley ER. 2006. Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol 18:39-48.
22. Clatworthy AL, Illich PA, Castro GA, Walters ET. 1995. Role of periaxonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain. Neurosci Lett 184:5-8.
23. Cohen G, Makranz C, Spira M, Kodama T, Reichert F, Rotshenker S. 2006. Non-PKC DAG/phorbol-ester receptor(s) inhibit complement receptor- 3 and nPKC inhibit scavenger receptor-AI/II-mediated myelin phagocytosis but cPKC, PI3k, and PLCg activate myelin phagocytosis by both. Glia 53:538-550.
24. Coleman MP, Conforti L, Buckmaster EA, Tarlton A, Ewing RM, Brown MC, Lyon MF, Perry VH. 1998. An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse. Proc Natl Acad Sci USA 95:9985-9990.
25. Coleman MP, Perry VH. 2002. Axon pathology in neurological disease: A neglected therapeutic target. Trends Neurosci 25:532-537.
26. Crawford TO, Griffin JW. 1991. Morphometrical and ultrastructural evaluation of the sural nerve in children with Charcot-Marie-Tooth: Implication for pathogenesis and treatment. Ann Neurol 30:500
27. Crocker PR. 2002. Siglecs: Sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling. Curr Opin Struct Biol 12:609-615.
28. Crocker PR. 2005. Siglecs in innate immunity. Curr Opin Pharmacol 5:431-437.
29. Crocker PR, Mucklow S, Bouckson V, McWilliam A, Willis AC, Gordon S, Milon G, Kelm S, Bradfield P. 1994. Sialoadhesin, a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin- like domains. Embo J 13:4490-4503.
30. Crocker PR, Varki A. 2001. Siglecs in the immune system. Immunology 103:137-145.
31. David S, Fry EJ, Lopez-Vales R. 2008. Novel roles for Nogo receptor in inflammation and disease. Trends Neurosci 31:221-226.
32. De S, Trigueros MA, Kalyvas A, David S. 2003. Phospholipase A2 plays an important role in myelin breakdown and phagocytosis during Wallerian degeneration. Mol Cell Neurosci 24:753-765.
33. Dennis EA. 2000. Phospholipase A2 in eicosanoid generation. Am J Respir Crit Care Med 161(2 Part 2):S32-S35.
34. Ey B, Kobsar I, Blazyca H, Kroner A, Martini R. 2007. Visualization of degenerating axons in a dysmyelinating mouse mutant with axonal loss. Mol Cell Neurosci 35:153-160.
35. Fernandez-Valle C, Bunge RP, Bunge MB. 1995. Schwann cells degrade myelin and proliferate in the absence of macrophages: Evidence from in vitro studies of Wallerian degeneration. J Neurocytol 24:667-679.
36. Fischer S, Kleinschnitz C, Muller M, Kobsar I, Ip CW, Rollins B, Martini R. 2008a. Monocyte chemoattractant protein-1 is a pathogenic component in a model for a hereditary peripheral neuropathy. Mol Cell Neurosci 37:359-366.
37. Fischer S, Weishaupt A, Troppmair J, Martini R. 2008b. Increase of MCP-1 (CCL2) in myelin mutant Schwann cells is mediated by MEKERK signaling pathway. Glia 56:836-843.
38. Flugel A, Hager G, Horvat A, Spitzer C, Singer GM, Graeber MB, Kreutzberg GW, Schwaiger FW. 2001. Neuronal MCP-1 expression in response to remote nerve injury. J Cereb Blood Flow Metab 21:69-76.
39. Fry EJ, Ho C, David S. 2007. A role for Nogo receptor in macrophage clearance from injured peripheral nerve. Neuron 53:649-62.
40. George A, Kleinschnitz C, Zelenka M, Brinkhoff J, Stoll G, Sommer C. 2004. Wallerian degeneration after crush or chronic constriction injury of rodent sciatic nerve is associated with a depletion of endoneurial interleukin-10 protein. Exp Neurol 188:187-191.
41. George A, Schmidt C, Weishaupt A, Toyka KV, Sommer C. 1999. Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury. Exp Neurol 160:124-132.
42. George R, Griffin JW. 1994. Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: The dorsal radiculotomy model. Exp Neurol 129:225-236.
43. Gillen C, Jander S, Stoll G. 1998. Sequential expression of mRNA for proinflammatory cytokines and interleukin-10 in the rat peripheral nervous system: Comparison between immune-mediated demyelination and Wallerian degeneration. J Neurosci Res 51:489-496.
44. Gordon S, Crocker PR, Morris L, Lee SH, Perry VH, Hume DA. 1986. Localization and function of tissue macrophages. Ciba Found Symp 118:54-67.
45. Gordon S, Lawson L, Rabinowitz S, Crocker PR, Morris L, Perry VH. 1992. Antigen markers of macrophage differentiation in murine tissues. Curr Top Microbiol Immunol 181:1-37.
46. Gregson NA, Hall SM. 1973. A quantitative analysis of the effects of the intraneural injection of lysophosphatidyl choline. J Cell Sci 13:257-277.
47. Hack CE, Wolbink GJ, Schalkwijk C, Speijer H, Hermens WT, van den Bosch H. 1997. A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells. Immunol Today 18:111-115.
48. Hall SM, Gregson NA. 1971. The in vivo and ultrastructural effects of injection of lysophosphatidyl choline into myelinated peripheral nerve fibres of the adult mouse. J Cell Sci 9:769-789.
49. Huang D, Han Y, Rani MR, Glabinski A, Trebst C, Sorensen T, Tani M, Wang J, Chien P, O'Bryan S, Bielecki B, Zhou ZL, Majumder S, Ransohoff RM. 2000. Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol Rev 177:52-67.
50. Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM. 2001. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 193:713-726.
51. Hughes EH, Schlichtenbrede FC, Murphy CC, Sarra GM, Luthert PJ, Ali RR, Dick AD. 2003. Generation of activated sialoadhesin-positive microglia during retinal degeneration. Invest Ophthalmol Vis Sci 44:2229-2234.
52. Ip CW, Kroner A, Bendszus M, Leder C, Kobsar I, Fischer S, Wiendl H, Nave KA, Martini R. 2006. Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes. J Neurosci 26:8206-8216.
53. Ip CW, Kroner A, Crocker PR, Nave KA, Martini R. 2007. Sialoadhesin deficiency ameliorates myelin degeneration and axonopathic changes in the CNS of PLP overexpressing mice. Neurobiol Dis 25:105- 111.
54. Jander S, Pohl J, Gillen C, Stoll G. 1996. Differential expression of interleukin-10 mRNA in Wallerian degeneration and immune-mediated inflammation of the rat peripheral nervous system. J Neurosci Res 43:254-259.
55. Jiang HR, Hwenda L, Makinen K, Oetke C, Crocker PR, Forrester JV. 2006. Sialoadhesin promotes the inflammatory response in experimental autoimmune uveoretinitis. J Immunol 177:2258-2264.
56. Kalla R, Liu Z, Xu S, Koppius A, Imai Y, Kloss CU, Kohsaka S, Gschwendtner A, Moller JC, Werner A, Raivich G. 2001. Microglia and the early phase of immune surveillance in the axotomized facial motor nucleus: Impaired microglial activation and lymphocyte recruitment but no effect on neuronal survival or axonal regeneration in macrophage-colony stimulating factor-deficient mice. J Comp Neurol 436:182-201.
57. Karanth S, Yang G, Yeh J, Richardson PM. 2006. Nature of signals that initiate the immune response during Wallerian degeneration of peripheral nerves. Exp Neurol 202:161-166.
58. Kleinschnitz C, Brinkhoff J, Zelenka M, Sommer C, Stoll G. 2004. The extent of cytokine induction in peripheral nerve lesions depends on the mode of injury and NMDA receptor signaling. J Neuroimmunol 149:77-83.
59. Kobsar I, Hasenpusch-Theil K, Wessig C, Muller HW, Martini R. 2005. Evidence for macrophage-mediated myelin disruption in an animal model for Charcot-Marie-Tooth neuropathy type 1A. J Neurosci Res 81:857-864.
60. Kobsar I, Maurer M, Ott T, Martini R. 2002. Macrophage-related demyelination in peripheral nerves of mice deficient in the gap junction protein connexin 32. Neurosci Lett 320:17-20.
61. Kobsar I, Oetke C, Kroner A, Wessig C, Crocker P, Martini R. 2006. Attenuated demyelination in the absence of the macrophage-restricted adhesion molecule sialoadhesin (Siglec-1) in mice heterozygously deficient in P0. Mol Cell Neurosci 31:685-691.
62. Kuhlmann T, Bitsch A, Stadelmann C, Siebert H, Bruck W. 2001. Macrophages are eliminated from the injured peripheral nerve via local apoptosis and circulation to regional lymph nodes and the spleen. J Neurosci 21:3401-3408.
63. La Fleur M, Underwood JL, Rappolee DA, Werb Z. 1996. Basement membrane and repair of injury to peripheral nerve: Defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J Exp Med 184:2311-2326.
64. Larsen PH, Wells JE, Stallcup WB, Opdenakker G, Yong VW. 2003. Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. J Neurosci 23:11127-11135.
65. Lauber K, Bohn E, Krober SM, Xiao YJ, Blumenthal SG, Lindemann RK, Marini P, Wiedig C, Zobywalski A, Baksh S, Xu Y, Autenrieth IB, Schulz-Osthoff K, Belka C, Stühler G, Wesselborg S. 2003. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113:717-730.
66. Lee H, Jo EK, Choi SY, Oh SB, Park K, Kim JS, Lee SJ. 2006. Necrotic neuronal cells induce inflammatory Schwann cell activation via TLR2 and TLR3: Implication in Wallerian degeneration. Biochem Biophys Res Commun 350:742-747.
67. Liefner M, Siebert H, Sachse T, Michel U, Kollias G, Bruck W. 2000. The role of TNF-a during Wallerian degeneration. J Neuroimmunol 108:147-152.
68. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, North R, Gerard C, Rollins BJ. 1998. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 187:601-608.
69. Mack TG, Reiner M, Beirowski B, Mi W, Emanuelli M, Wagner D, Thomson D, Gillingwater T, Court F, Conforti L, Fernando FS, Tarlton A, Andressen C, Addicks K, Magni G, Ribchester RR, Perry VH, Coleman MP. 2001. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci 4:1199-1206.
70. Makranz C, Cohen G, Baron A, Levidor L, Kodama T, Reichert F, Rotshenker S. 2004. Phosphatidylinositol 3-kinase, phosphoinositide-specific phospholipase-Cg and protein kinase-C signal myelin phagocytosis mediated by complement receptor-3 alone and combined with scavenger receptor-AI/II in macrophages. Neurobiol Dis 15:279- 286.
71. Makranz C, Cohen G, Reichert F, Kodama T, Rotshenker S. 2006. cAMP cascade (PKA, Epac, adenylyl cyclase, Gi, and phosphodiesterases) regulates myelin phagocytosis mediated by complement receptor- 3 and scavenger receptor-AI/II in microglia and macrophages Glia 53:441-448.
72. Martini R. 1994. Expression and functional roles of neural cell surface molecules and extracellular matrix components during development and regeneration of peripheral nerves. J Neurocytol 23:1-28.
73. Martini R, Toyka KV. 2004. Immune-mediated components of hereditary demyelinating neuropathies: Lessons from animal models and patients. Lancet Neurol 3:457-465.
74. Martini R, Zielasek J, Toyka KV, Giese KP, Schachner M. 1995. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat Genet 11:281-286.
75. Maurer M, Muller M, Kobsar I, Leonhard C, Martini R, Kiefer R. 2003. Origin of pathogenic macrophages and endoneurial fibroblast-like cells in an animal model of inherited neuropathy. Mol Cell Neurosci 23:351-359.
76. McKerracher L, David S. 2004. Easing the brakes on spinal cord repair. Nat Med 10:1052-1053.
77. Mueller M, Wacker K, Ringelstein EB, Hickey WF, Imai Y, Kiefer R. 2001. Rapid response of identified resident endoneurial macrophages to nerve injury. Am J Pathol 159:2187-2197.
78. Muller HW, Minwegen P. 1987. Nonresident macrophages in peripheral nerve of rat: Effect of silica on migration, myelin phagocytosis, and apolipoprotein E expression during Wallerian degeneration. J Neurosci Res 18:222-229.
79. Muller M, Berghoff M, Kobsar I, Kiefer R, Martini R. 2007. Macrophage colony stimulating factor is a crucial factor for the intrinsic macrophage response in mice heterozygously deficient for the myelin protein P0. Exp Neurol 203:55-62.
80. Munday J, Floyd H, Crocker PR. 1999. Sialic acid binding receptors (siglecs) expressed by macrophages. J Leukoc Biol 66:705-711.
81. Murakami M, Nakatani Y, Atsumi G, Inoue K, Kudo I. 1997. Regulatory functions of phospholipase A2. Crit Rev Immunol 17:225-283.
82. Niemann A, Berger P, Suter U. 2006. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease. Neuromolecular Med 8:217-242.
83. Ousman SS, David S. 2000. Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 30:92-104.
84. Ousman SS, David S. 2001. MIP-1a, MCP-1, GM-CSF, and TNF-a control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord J Neurosci 21:4649-4656.
85. Pennuto M, Tinelli E, Malaguti M, Del Carro U, D'Antonio M, Ron D, Quattrini A, Feltri ML, Wrabetz L. 2008. Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice. Neuron 57:393-405.
86. Perrin FE, Lacroix S, Aviles-Trigueros M, David S. 2005. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1a and interleukin-1b in Wallerian degeneration. Brain 128(Part 4):854-866.
87. Perry VH, Crocker PR, Gordon S. 1992. The blood-brain barrier regulates the expression of a macrophage sialic acid-binding receptor on microglia. J Cell Sci 101(Part 1):201-207.
88. Pixley FJ, Stanley ER. 2004. CSF-1 regulation of the wandering macrophage: Complexity in action. Trends Cell Biol 14:628-638.
89. Pot C, Simonen M, Weinmann O, Schnell L, Christ F, Stoeckle S, Berger P, Rulicke T, Suter U, Schwab ME. 2002. Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury. J Cell Biol 159:29-35.
90. Raivich G, Bohatschek M, Kloss CU, Werner A, Jones LL, Kreutzberg GW. 1999. Neuroglial activation repertoire in the injured brain: Graded response, molecular mechanisms and cues to physiological function. Brain Res Brain Res Rev 30:77-105.
91. Reichert F, Rotshenker S. 1996. Deficient activation of microglia during optic nerve degeneration. J Neuroimmunol 70:153-161.
92. Reichert F, Rotshenker S. 2003. Complement-receptor-3 and scavengerreceptor- AI/II mediated myelin phagocytosis in microglia and macrophages. Neurobiol Dis 12:65-72.
93. Rotshenker S. 2003. Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3/MAC-1)-mediated myelin phagocytosis in injury and disease. J Mol Neurosci 21:65-72.
94. Saada A, Reichert F, Rotshenker S. 1996. Granulocyte macrophage colony stimulating factor produced in lesioned peripheral nerves induces the up-regulation of cell surface expression of MAC-2 by macrophages and Schwann cells. J Cell Biol 133:159-167.
95. Sawada T, Sano M, Omura T, Omura K, Hasegawa T, Funahashi S, Nagano A. 2007. Spatiotemporal quantification of tumor necrosis factor- a and interleukin-10 after crush injury in rat sciatic nerve utilizing immunohistochemistry. Neurosci Lett 417:55-60.
96. Schmid CD, Stienekemeier M, Oehen S, Bootz F, Zielasek J, Gold R, Toyka KV, Schachner M, Martini R. 2000. Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance. J Neurosci 20:729-735.
97. Schwab JM, Serhan CN. 2006. Lipoxins and new lipid mediators in the resolution of inflammation. Curr Opin Pharmacol 6:414-420.
98. Serbina NV, Pamer EG. 2006. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 7:311-317.
99. Serhan CN. 2007. Resolution phase of inflammation: Novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 25:101-137.
100. Shamash S, Reichert F, Rotshenker S. 2002. The cytokine network of Wallerian degeneration: Tumor necrosis factor-a, interleukin-1a, and interleukin-1b. J Neurosci 22:3052-3060.
101. Shy ME, Arroyo E, Sladky J, Menichella D, Jiang H, Xu W, Kamholz J, Scherer SS. 1997. Heterozygous P0 knockout mice develop a peripheral neuropathy that resembles chronic inflammatory demyelinating polyneuropathy (CIDP). J Neuropathol Exp Neurol 56:811-821.
102. Siebert H, Dippel N, Mader M, Weber F, Bruck W. 2001. Matrix metalloproteinase expression and inhibition after sciatic nerve axotomy. J Neuropathol Exp Neurol 60:85-93.
103. Siebert H, Sachse A, Kuziel WA, Maeda N, Bruck W. 2000. The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system. J Neuroimmunol 110:177-185.
104. Siglienti I, Bendszus M, Kleinschnitz C, Stoll G. 2006. Cytokine profile of iron-laden macrophages: Implications for cellular magnetic resonance imaging. J Neuroimmunol 173:166-173.
105. Stoll G, Jander S, Myers RR. 2002. Degeneration and regeneration of the peripheral nervous system: From Augustus Waller's observations to neuroinflammation. J Peripher Nerv Syst 7:13-27.
106. Stoll G, Jung S, Jander S, van der Meide P, Hartung HP. 1993. Tumor necrosis factor-a in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J Neuroimmunol 45:175-182.
107. Subang MC, Richardson PM. 2001. Influence of injury and cytokines on synthesis of monocyte chemoattractant protein-1 mRNA in peripheral nervous tissue. Eur J Neurosci 13:521-528.
108. Takahashi M, Kawaguchi M, Shimada K, Konishi N, Furuya H, Nakashima T. 2004. Cyclooxygenase-2 expression in Schwann cells and macrophages in the sciatic nerve after single spinal nerve injury in rats. Neurosci Lett 363:203-206.
109. Taskinen HS, Olsson T, Bucht A, Khademi M, Svelander L, Roytta M. 2000. Peripheral nerve injury induces endoneurial expression of IFNg, IL-10 and TNF-a mRNA. J Neuroimmunol 102:17-25.
110. Taskinen HS, Roytta M. 2000. Increased expression of chemokines (MCP-1, MIP-1a, RANTES) after peripheral nerve transection. J Peripher Nerv Syst 5:75-81.
111. Teitelbaum SL. 2000. Bone resorption by osteoclasts. Science 289:1504- 1508.
112. Toews AD, Barrett C, Morell P. 1998. Monocyte chemoattractant protein 1 is responsible for macrophage recruitment following injury to sciatic nerve. J Neurosci Res 53:260-267.
113. Tofaris GK, Patterson PH, Jessen KR, Mirsky R. 2002. Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J Neurosci 22:6696-6703.
114. Venkatesh K, Chivatakarn O, Lee H, Joshi PS, Kantor DB, Newman BA, Mage R, Rader C, Giger RJ. 2005. The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein. J Neurosci 25:808-822.
115. Vital A, Vital C, Julien J, Fontan D. 1992. Occurrence of active demyelinating lesions in children with hereditary motor and sensory neuropathy (HMSN) type I. Acta Neuropathol 84:433-436.
116. Vital A, Vital C, Lagueny A, Ferrer X, Ribiere-Bachelier C, Latour P, Petry KG. 2003. Inflammatory demyelination in a patient with CMT1A. Muscle Nerve 28:373-376.
117. Volanakis JE, Wirtz KW. 1979. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature 281:155-157.
118. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. 1997. Immunosuppressive effects of apoptotic cells. Nature 390:350- 351.
119. Wagner R, Myers RR. 1996. Schwann cells produce tumor necrosis factor a: expression in injured and non-injured nerves. Neuroscience 73:625-629.
120. Waller A. 1850. Experiments on the section of the glassopharyngeal abd hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primary fibers. Phil Trans R Soc London (Biol) 140:423-429.
121. Yang DP, Zhang DP, Mak KS, Bonder DE, Pomeroy SL, Kim HA. 2008. Schwann cell proliferation during Wallerian degeneration is not necessary for regeneration and remyelination of the peripheral nerves: Axon-dependent removal of newly generated Schwann cells by apoptosis. Mol Cell Neurosci 38:80-88.